Evidence map›Paper›PMID 39849907›Full record

ArticleEpidemiology and infection2025

Risk factors associated with IgG seropersistence to

Nea Koskela, Julia Butt, Birgitta E Michels, Kari Syrjänen, Seija Grenman, Tim Waterboer, Stina Syrjänen, Karolina Louvanto

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Epidemiology and infection, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nea KoskelaDepartment of Obstetrics and Gynecology, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.ORCID 0009-0002-0337-7420
Julia ButtGerman Cancer Research Center (DKFZ), Heidelberg, Germany.
Birgitta E MichelsGerman Cancer Research Center (DKFZ), Heidelberg, Germany.
Kari SyrjänenSMW Consultants, Ltd., Kaarina, Finland.
Seija GrenmanDepartment of Obstetrics and Gynecology, Turku University Hospital, University of Turku, Turku, Finland.
Tim WaterboerGerman Cancer Research Center (DKFZ), Heidelberg, Germany.
Stina SyrjänenDepartment of Oral Pathology, Institute of Dentistry, Faculty of Medicine, University of Turku, Turku, Finland.
Karolina LouvantoDepartment of Obstetrics and Gynecology, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.

Funding

Päivikki ja Sakari Sohlbergin SäätiöResearch Council of FinlandSigrid Juséliuksen SäätiöSuomen Lääketieteen Säätiö
6 · The paper itself

Abstract

Sexually transmitted infections caused by

Indexed as

Antibodies, BacterialChlamydia InfectionsChlamydia trachomatisImmunoglobulin GMycoplasma genitaliumMycoplasma InfectionsAdolescentAdultFemaleFinlandHumansMaleMiddle AgedPregnancyRisk FactorsSeroepidemiologic StudiesAntibodies, BacterialImmunoglobulin GBacterial infectionsChlamydiaMycoplasmaSerologySexually transmitted infections (STIs)

Identifiers

PMID39849907
PMCPMC12455505

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.